Sarcoma | Clinical

July 22, 2021

A phase 3 study has been initiated in order to evaluate the efficacy of the oral MDM2 inhibitor milademetan for the treatment of de-differentiated liposarcoma.

June 28, 2021

The target number of patients with soft tissue sarcoma lung metastases have been enrolled in the phase 1b/2 study of Annamycin, commencing the recruiting portion of the trial.

June 05, 2021

New data from the phase 2 SPEARHEAD-1 trial showed that afami-cel can elicit encouraging responses in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma.

June 04, 2021

Progression-free survival and disease control in patients with advanced synovial sarcoma was improved by catequentinib.

May 07, 2021

Brian Van Tine, MD, PhD, and Fadi Braiteh, MD, discuss unmet needs in the treatment of gastrointestinal stromal tumors (GISTs) and look to the future in terms of the evolving field.

May 07, 2021

Experts discuss the role of multidisciplinary management for patients with gastrointestinal stromal tumors (GISTs).

April 23, 2021

Implications for treating patients with gastrointestinal stromal tumors (GISTs) in the later lines of therapy after switching from 1 treatment to another.

April 23, 2021

Brian Van Tine, MD, PhD, and Fadi Braiteh, MD, discuss the current treatment options that are available for the treatment of gastrointestinal stromal tumor (GIST).

April 23, 2021

An overview of mutations in gastrointestinal stromal tumor (GIST) and how they can influence treatment selection.

April 23, 2021

Considerations for gastrointestinal stromal tumor (GIST) sequencing in the adjuvant setting.